Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro has not gone down in price in the UK — the opposite happened. From 1 September 2025, Eli Lilly raised the list price of tirzepatide significantly, with the highest-dose pen rising from around £122 to around £330 per four-week pen. Private providers have adjusted accordingly, and the days of lower entry-level pricing are, for now, behind us. These are prescription-only medicines; a prescriber must assess your suitability before any supply is authorised.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The short answer to whether the price of Mounjaro has gone down: it has not. Eli Lilly's list-price increase on 1 September 2025 was steep at the higher doses, the per-pen cost for the 15mg pen roughly tripled compared to earlier in 2025. Private providers, whose pricing tracks the licensed supply chain, moved with it. Typical private market prices since then range from roughly £149 to £375 per month, varying by dose and clinic, as widely reported in August and September 2025.
It is worth knowing what drives that range. The starter dose (2.5mg) sits at the lower end; the maintenance doses carry the higher figures. Titration is clinically guided (a prescriber decides when and whether to increase, not a fixed timetable) so the dose you end up on is not something that can be predicted at sign-up. Our detailed breakdown of Mounjaro pricing in the UK walks through how the dose ladder affects what you actually spend month to month.
If you want a clear picture of how much Mounjaro shots cost at each dose, that page sets out the current per-pen figures across the full titration range in one place. If you are also wondering whether Mounjaro will come down in price in the months ahead, we have a dedicated page looking at what the evidence and manufacturer signals actually suggest. To check today's position in under a minute, you can also visit the Eli Lilly UK or NICE websites for the latest published list-price information, these are publicly accessible and update when manufacturers formally notify them. That habit is far more reliable than a Reddit thread from six months ago.
Seeing a monthly figure online does not mean that is all you pay. Several things are routinely absent from the advertised price: an initial consultation fee, a separate prescription charge, delivery costs, and any ongoing clinical support if you have questions between orders. Taken together these can add meaningfully to the headline figure.
There is also the question of what happens when you need a dose review. A clinical reassessment before each repeat (checking your progress, confirming suitability, adjusting the dose where needed) takes real prescriber time. Some services bill for that separately or include it only at certain intervals. Understanding the full cost before you commit matters as much as the month-one figure.
Our frequently asked questions cover the process in plain language if you want to understand exactly what a legitimate private prescription service involves at each stage. The weight-loss treatment overview also sets out how the different options compare.
We are not the cheapest option on the market. That is a deliberate position, not an oversight. Our single price covers the consultation, the prescription, the medicine, tracked next-working-day delivery and priority aftercare seven days a week. There is no subscription, no auto-renewal, and no clinical review skipped because it costs us more to do it properly. Every repeat order is assessed afresh by a GPhC-registered Independent Prescriber before anything is dispatched.
For context on how we operate, the about us page explains the pharmacy's GPhC registration (premises number 9012878, verifiable at the GPhC register) and the clinical infrastructure behind every order. Treatment pricing is shown on the treatment page, we do not print per-pen prices in body copy, because those figures shift as your dose progresses and a single number would mislead more than it informs.
A low price is appealing. But for a prescription-only medicine like Mounjaro, the question of where it comes from matters as much as what it costs. The MHRA has issued repeated warnings about counterfeit weight-loss pens sold online, fake products have caused hospitalisations, and enforcement operations in 2025 seized around 20 million doses of illegally traded weight-loss medicines at an estimated street value of around £45 million. Saving £30 a month from an unverified seller is not actually a saving if the product is counterfeit.
Any legitimate supplier operates through the licensed UK supply chain and can be verified on the GPhC register. If a seller is offering Mounjaro at prices well below the market range, or without a clinical assessment, that is the signal, not a deal. You can report suspect sellers directly through the MHRA Yellow Card scheme, which exists for exactly that reason.
For anyone tracking how prices might move from here, we have a dedicated page looking at whether Mounjaro prices will go down, and a separate piece covering what drove the September 2025 increase in the first place. If you are also wondering whether Mounjaro has come down in price since the rises earlier this year, that page looks at what the data actually shows. Neither contains speculation; both stick to what manufacturers and regulators have actually said. If you are ready to explore whether treatment is right for you, you can start your free consultation with no obligation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.